Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 25, Issue 1, Pages 4-9
Publisher
Wiley
Online
2017-10-20
DOI
10.1111/jvh.12807
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
- (2016) Patrick Marcellin et al. GASTROENTEROLOGY
- Historical review on thymosin α1 in oncology: preclinical and clinical experiences
- (2015) Enrico Garaci et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Thymosin alpha-1 treatment in chronic hepatitis B
- (2015) Xiaoning Wu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
- (2015) Barbara Rehermann et al. HEPATOLOGY
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
- (2015) Anna S.F. Lok et al. HEPATOLOGY
- Management of chronic hepatitis B infection
- (2015) V. Sundaram et al. BMJ-British Medical Journal
- Management of chronic hepatitis B infection
- (2015) V. Sundaram et al. BMJ-British Medical Journal
- O3 ADDING PEGINTERFERON TO ENTECAVIR INCREASES RESPONSE RATES IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: WEEK 96 RESULTS OF A GLOBAL MULTICENTER RANDOMISED TRIAL (ARES STUDY)
- (2014) W.P. Brouwer et al. JOURNAL OF HEPATOLOGY
- Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
- (2014) Jorg Petersen et al. LIVER INTERNATIONAL
- Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments
- (2014) Ceen-Ming Tang WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
- (2012) Bo Hyun Kim et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1
- (2010) Claudia Matteucci et al. Annals of the New York Academy of Sciences
- Thymosin alpha 1: past clinical experience and future promise
- (2010) Cynthia Tuthill et al. Annals of the New York Academy of Sciences
- Serum HBsAg levels during peginterferon α-2a treatment with or without thymosin α-1 in HBeAg-positive chronic hepatitis B patients
- (2010) Eun Young Song et al. JOURNAL OF MEDICAL VIROLOGY
- From lab to bedside: emerging clinical applications of thymosin α1
- (2009) Allan L Goldstein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
- (2009) Yuan-Yuan Zhang et al. Virology Journal
- Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis
- (2007) Yong-Feng Yang et al. ANTIVIRAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started